These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1377 related articles for article (PubMed ID: 22436845)

  • 1. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.
    European Association For The Study Of The Liver
    J Hepatol; 2012 Jul; 57(1):167-85. PubMed ID: 22436845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Updates of EASL clinical practice guidelines: management of chronic hepatitis B virus infection].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):427-9. PubMed ID: 23230593
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatitis B: who, when, and how?
    Wong SN; Lok AS
    Arch Intern Med; 2006 Jan; 166(1):9-12. PubMed ID: 16401805
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
    Bronowicki JP; Barraud H; Couzigou P
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
    Mauss S; Wedemeyer H
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of HBeAg negative chronic hepatitis B].
    Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):539. PubMed ID: 16042896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Marcellin P; Lada O
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
    [No Abstract]   [Full Text] [Related]  

  • 11. Selecting appropriate management strategies for chronic hepatitis B: who to treat.
    McMahon BJ
    Am J Gastroenterol; 2006; 101 Suppl 1():S7-12. PubMed ID: 16448451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HBV mutations during antiviral therapy in patients with chronic hepatitis B].
    Hwang SG
    Korean J Hepatol; 2005 Dec; 11(4):311-9. PubMed ID: 16380660
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?
    Zoulim F
    Hepatology; 2006 Dec; 44(6):1404-7. PubMed ID: 17133478
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of hepatitis B patients with antiviral resistance.
    Fung SK; Lok AS
    Antivir Ther; 2004 Dec; 9(6):1013-26. PubMed ID: 15651760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus antiviral drug resistance: from the laboratory to the patient.
    Mutimer D
    Antivir Ther; 1998; 3(4):243-6. PubMed ID: 10682147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. South African guideline for the management of chronic hepatitis B: 2013.
    Spearman CW; Sonderup MW; Botha JF; van der Merwe SW; Song E; Kassianides C; Newton KA; Hairwadzi HN;
    S Afr Med J; 2013 May; 103(5 Pt 2):337-49. PubMed ID: 23967497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
    Yokosuka O
    J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidrug resistance after lamivudine therapy for chronic hepatitis B.
    Sarrecchia C; Volpi A; Sordillo P; Andreoni M
    Int J Infect Dis; 2009 May; 13(3):e133-4. PubMed ID: 18990599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of hepatitis B in pregnancy: a challenge.
    Kamani L
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):73. PubMed ID: 24411551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 69.